NEW YORK (GenomeWeb News) – Thermo Fisher Scientific took charges totaling $31.0 million during the first half of 2013 associated with a reduction in headcount of approximately 655 employees, the company said in its Form 10-Q filed on Friday.

In the second quarter, the company took charges of $12.8 million associated with a reduction in headcount of 340 employees, though it is unclear when the headcount reductions occurred.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.